Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [ComirnatyⓇ])-Reference-Cited by-同舟云学术

Acute asthma exacerbation due to the SARS-CoV-2 vaccine (Pfizer-BioNTech BNT162b2 messenger RNA COVID-19 vaccine [ComirnatyⓇ])

Published:2022-11 Issue: Volume:124 Page:187-189
ISSN:1201-9712
Container-title:International Journal of Infectious Diseases
language:en
Short-container-title:International Journal of Infectious Diseases

Author:

Ando Masaru^ORCID,Satonaga Yoshio,Takaki Ryuichiro,Yabe Michitoshi,Kan Takamasa,Omote Erika,Yamasaki Toru,Komiya Kosaku,Hiramatsu Kazufumi

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference10 articles.

1. COVID vaccination and asthma exacerbation: might there be a link?;Colaneri;Int J Infect Dis,2021

2. Recent advances and developments in COVID-19 in the context of allergic diseases;Ding;Clin Transl Allergy,2021

3. Eosinophils, bronchial hyperreactivity and late-phase asthmatic reactions;Durham;Clin Allergy,1985

4. Eosinophilic granulomatosis with polyangiitis diagnosed in an elderly female after the second dose of mRNA vaccine against COVID-19;Ibrahim;Cureus,2022

5. Three cases of drug-induced hypersensitivity syndrome associated with mRNA-based coronavirus disease 2019 vaccines;Korekawa;J Dermatol,2022

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 mRNA vaccination status and concerns among pregnant women in Japan: a multicenter questionnaire survey;BMC Pregnancy and Childbirth;2023-05-09

2. Coronavirus Disease 2019 Vaccine-Induced Flare-Up of Severe Bronchial Asthma Previously Controlled With Dupilumab: A Case Report;Cureus;2023-04-25

3. Colitis with Hypereosinophilia following the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine: A Case Report with a Literature Review;Internal Medicine;2023-03-15

4. Tozinameran;Reactions Weekly;2023-02-18

5. Nonepisodic Angioedema with Eosinophilia Following Receipt of the BNT162b2 mRNA COVID-19 Vaccine;Internal Medicine;2023